//
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes